Anatara Lifesciences (Australia) Buy Hold or Sell Recommendation
| ANR Stock | 0.06 0 1.72% |
Assuming the 90 days trading horizon and your complete indifference towards market risk, our recommendation regarding Anatara Lifesciences is 'Cautious Hold'. A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell Anatara Lifesciences given historical horizon and risk tolerance towards Anatara Lifesciences. When Macroaxis issues a 'buy' or 'sell' recommendation for Anatara Lifesciences, the advice is generated through an automated system that utilizes algorithms and statistical models.
Check out Anatara Lifesciences Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. Note, we conduct extensive research on individual companies such as Anatara and provide practical buy, sell, or hold advice based on investors' constraints. Anatara Lifesciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
Anatara |
Execute Anatara Lifesciences Buy or Sell Advice
The Anatara recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Anatara Lifesciences. Macroaxis does not own or have any residual interests in Anatara Lifesciences or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Anatara Lifesciences' advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Hold
Market Performance | Modest | Details | |
Volatility | Out of control | Details | |
Hype Condition | Under hyped | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | About Average | Details | |
Economic Sensitivity | Barely shadows the market | Details | |
Analyst Consensus | Not Available | Details | |
Reporting Quality (M-Score) | Inapplicable | Details |
Anatara Lifesciences Trading Alerts and Improvement Suggestions
| Anatara Lifesciences had very high historical volatility over the last 90 days | |
| Anatara Lifesciences has some characteristics of a very speculative penny stock | |
| Net Loss for the year was (1.45 M) with loss before overhead, payroll, taxes, and interest of (1.6 M). | |
| Anatara Lifesciences generates negative cash flow from operations | |
| About 30.0% of the company shares are held by company insiders | |
| Latest headline from news.google.com: Anatara Lifesciences Sees Increased Stake by TIGA Trading - TipRanks |
Anatara Lifesciences Returns Distribution Density
The distribution of Anatara Lifesciences' historical returns is an attempt to chart the uncertainty of Anatara Lifesciences' future price movements. The chart of the probability distribution of Anatara Lifesciences daily returns describes the distribution of returns around its average expected value. We use Anatara Lifesciences price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Anatara Lifesciences returns is essential to provide solid investment advice for Anatara Lifesciences.
| Mean Return | 0.50 | Value At Risk | -8.93 | Potential Upside | 7.69 | Standard Deviation | 5.36 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Anatara Lifesciences historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Anatara Lifesciences Cash Flow Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| End Period Cash Flow | 2.7M | 3.4M | 1.1M | 351.2K | 982.1K | 1.8M | |
| Change In Cash | 1.3M | 749.7K | (2.3M) | (769.0K) | 630.9K | 662.5K | |
| Free Cash Flow | (2.7M) | (2.1M) | (2.2M) | (2.3M) | (1.2M) | (1.3M) | |
| Other Non Cash Items | 72.0K | 272.7K | (106.4K) | 442.9K | (170.4K) | (161.9K) | |
| Net Income | (3.4M) | (2.0M) | (2.5M) | (2.0M) | (1.5M) | (1.5M) | |
| Investments | 4.1M | (4.0K) | (50K) | (1.7K) | 50K | 52.5K | |
| Depreciation | 16.1K | 6.3K | 24.7K | 24.8K | 2.5K | 2.3K | |
| Change To Netincome | 305.5K | 117.9K | 74.8K | 70.9K | 63.8K | 60.6K | |
| Change To Inventory | (931.9K) | 732.8K | 64.1K | (165.2K) | (190.0K) | (180.5K) |
Anatara Lifesciences Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Anatara Lifesciences or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Anatara Lifesciences' price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Anatara stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | 0.49 | |
β | Beta against Dow Jones | 0.03 | |
σ | Overall volatility | 5.41 | |
Ir | Information ratio | 0.07 |
Anatara Lifesciences Volatility Alert
Anatara Lifesciences exhibits above-average semi-deviation for your current time horizon. Anatara Lifesciences is a penny stock. Although Anatara Lifesciences may be in fact a good investment, many penny stocks are subject to artificial price hype. Make sure you completely understand the upside potential and downside risk of investing in Anatara Lifesciences. We encourage investors to look for signals such as message board hypes, claims of breakthroughs, email spams, sudden volume upswings, and other similar hype indicators. We also encourage traders to check biographies and work history of company officers before investing in instruments with high volatility. You can indeed make money on Anatara instrument if you perfectly time your entry and exit. However, remember that penny stocks that have been the subject of artificial hype usually unable to maintain their increased share price for more than just a few days. The price of a promoted high volatility instrument will almost always revert back. The only way to increase shareholder value is through legitimate performance backed up by solid fundamentals.Anatara Lifesciences Fundamentals Vs Peers
Comparing Anatara Lifesciences' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Anatara Lifesciences' direct or indirect competition across all of the common fundamentals between Anatara Lifesciences and the related equities. This way, we can detect undervalued stocks with similar characteristics as Anatara Lifesciences or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Anatara Lifesciences' fundamental indicators could also be used in its relative valuation, which is a method of valuing Anatara Lifesciences by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Anatara Lifesciences to competition |
| Fundamentals | Anatara Lifesciences | Peer Average |
| Return On Equity | -1.27 | -0.31 |
| Return On Asset | -0.59 | -0.14 |
| Operating Margin | 2.85 % | (5.51) % |
| Current Valuation | 10.56 M | 16.62 B |
| Shares Outstanding | 207.89 M | 571.82 M |
| Shares Owned By Insiders | 29.97 % | 10.09 % |
| Shares Owned By Institutions | 12.89 % | 39.21 % |
| Price To Book | 8.68 X | 9.51 X |
| Price To Sales | 6.31 X | 11.42 X |
| Revenue | (123.18 K) | 9.43 B |
| Gross Profit | (1.6 M) | 27.38 B |
| EBITDA | (1.46 M) | 3.9 B |
| Net Income | (1.45 M) | 570.98 M |
| Total Debt | 306.85 K | 5.32 B |
| Book Value Per Share | 0.01 X | 1.93 K |
| Cash Flow From Operations | (1.25 M) | 971.22 M |
| Earnings Per Share | (0.01) X | 3.12 X |
| Target Price | 1.79 | |
| Beta | 0.81 | -0.15 |
| Market Capitalization | 11.85 M | 19.03 B |
| Total Asset | 1.67 M | 29.47 B |
| Retained Earnings | (22.09 M) | 9.33 B |
| Working Capital | 1.37 M | 1.48 B |
| Net Asset | 1.67 M |
Anatara Lifesciences Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Anatara . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Daily Balance Of Power | (9,223,372,036,855) | |||
| Rate Of Daily Change | 0.98 | |||
| Day Median Price | 0.057 | |||
| Day Typical Price | 0.057 | |||
| Price Action Indicator | (0.0005) | |||
| Period Momentum Indicator | (0) |
About Anatara Lifesciences Buy or Sell Advice
When is the right time to buy or sell Anatara Lifesciences? Buying financial instruments such as Anatara Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Anatara Lifesciences in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Furniture Thematic Idea Now
Furniture
Companies producing and selling home and office furniture. The Furniture theme has 40 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Furniture Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Anatara Stock Analysis
When running Anatara Lifesciences' price analysis, check to measure Anatara Lifesciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Anatara Lifesciences is operating at the current time. Most of Anatara Lifesciences' value examination focuses on studying past and present price action to predict the probability of Anatara Lifesciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Anatara Lifesciences' price. Additionally, you may evaluate how the addition of Anatara Lifesciences to your portfolios can decrease your overall portfolio volatility.